Cometriq: Difference between revisions
Jump to navigation
Jump to search
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{ | {{Definitions | ||
|Short definition=Cometriq - {{ | |Term=Cometriq | ||
|Type= | |Short definition=Cometriq - {{Pronunciation}} (koh-MEH-trik) A drug that contains the active substance cabozantinib s-malate and is used to treat progressive medullary thyroid cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Cometriq blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Cometriq is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor | ||
|Type=Cancer terms | |||
|Specialty=Oncology | |||
|Language=English | |||
|Source=NCI | |||
}} | }} | ||
Cometriq - {{Pronunciation}} (koh-MEH-trik) A drug that contains the active substance cabozantinib s-malate and is used to treat progressive medullary thyroid cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Cometriq blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Cometriq is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor {{dictionary-stub}} [[Category:Dictionary of medicine]] | |||
Latest revision as of 08:39, 8 January 2023
| Cometriq | |
|---|---|
| Term | Cometriq |
| Short definition | Cometriq - (pronounced) (koh-MEH-trik) A drug that contains the active substance cabozantinib s-malate and is used to treat progressive medullary thyroid cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Cometriq blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Cometriq is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Cometriq - (pronounced) (koh-MEH-trik) A drug that contains the active substance cabozantinib s-malate and is used to treat progressive medullary thyroid cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Cometriq blocks certain proteins that can prevent cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Cometriq is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor
External links
- Medical encyclopedia article on Cometriq
- Wikipedia's article - Cometriq
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski